
Top news of the day from across the health care landscape.

Five-day adjuvant IVIG therapy found to significantly reduce viral load in an immunocompromised patient with severe varicella.

The FDA has previously sent warning letters to other companies for illegally selling CBD products that had claimed to prevent, diagnose, mitigate, treat, or cure serious diseases, such as cancer.

The trial identified HIV-1 virus characteristics to predict treatment efficacy with a specific antibody treatment using sequence-based methods.

Researchers have identified a channel in nerve cells that may serve as a new approach to targeting Parkinson disease.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss during the future of data in Specialty Pharmacy at the NASP Annual Meeting in Washington, DC.

Jesse C. Dresser, Esq explains a recent piece of PBM legislation from North Dakota and its implications for specialty pharmacy at the NASP Annual Meeting in Washington, DC.

The approval was based on a phase 3 EDITION JUNIOR trial evaluating children and adolescents, aged 6 to 17 years, living with type 1 diabetes.
















In today’s fast-paced world, there are still family-owned pharmacies with a small-town vibe, including Lakes Apothecary.

The tool, which works by attaching a small sensor to the patient’s inhaler, collects data on medication use and sends medication reminders, progress reports, and disease insights to the patient’s smartphone or hub.

Top news of the day from across the health care landscape.

Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss value-based care and whether or not it poses challenge to data standardization in specialty pharmacy during the NASP Annual Meeting in Washington, DC.

The findings suggest that biologics can be used for those with elderly-onset rheumatoid arthritis (RA) as effectively as for those with young-onset RA.

Top news of the day from across the health care landscape.